These success, along with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,two support the principle of targeting ACKR3 as a novel technique to modulate the opioid system, which could open new therapeutic avenues for opioid-relevant disorders. As well as the described previously https://aloisk099hrb2.wikitron.com/user